220 related articles for article (PubMed ID: 19396443)
1. PTR1-dependent synthesis of tetrahydrobiopterin contributes to oxidant susceptibility in the trypanosomatid protozoan parasite Leishmania major.
Nare B; Garraway LA; Vickers TJ; Beverley SM
Curr Genet; 2009 Jun; 55(3):287-99. PubMed ID: 19396443
[TBL] [Abstract][Full Text] [Related]
2. The roles of pteridine reductase 1 and dihydrofolate reductase-thymidylate synthase in pteridine metabolism in the protozoan parasite Leishmania major.
Nare B; Hardy LW; Beverley SM
J Biol Chem; 1997 May; 272(21):13883-91. PubMed ID: 9153248
[TBL] [Abstract][Full Text] [Related]
3. Pteridine salvage throughout the Leishmania infectious cycle: implications for antifolate chemotherapy.
Cunningham ML; Beverley SM
Mol Biochem Parasitol; 2001 Apr; 113(2):199-213. PubMed ID: 11295174
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and genetic tests for inhibitors of Leishmania pteridine pathways.
Hardy LW; Matthews W; Nare B; Beverley SM
Exp Parasitol; 1997 Nov; 87(3):157-69. PubMed ID: 9371081
[TBL] [Abstract][Full Text] [Related]
5. PTR1: a reductase mediating salvage of oxidized pteridines and methotrexate resistance in the protozoan parasite Leishmania major.
Bello AR; Nare B; Freedman D; Hardy L; Beverley SM
Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11442-6. PubMed ID: 7972081
[TBL] [Abstract][Full Text] [Related]
6. Folate metabolic pathways in Leishmania.
Vickers TJ; Beverley SM
Essays Biochem; 2011; 51():63-80. PubMed ID: 22023442
[TBL] [Abstract][Full Text] [Related]
7. Combined gene deletion of dihydrofolate reductase-thymidylate synthase and pteridine reductase in Leishmania infantum.
Bhattacharya A; Leprohon P; Ouellette M
PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009377. PubMed ID: 33905412
[TBL] [Abstract][Full Text] [Related]
8. Role of the locus and of the resistance gene on gene amplification frequency in methotrexate resistant Leishmania tarentolae.
Kündig C; Leblanc E; Papadopoulou B; Ouellette M
Nucleic Acids Res; 1999 Sep; 27(18):3653-9. PubMed ID: 10471733
[TBL] [Abstract][Full Text] [Related]
9. Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development.
Cavazzuti A; Paglietti G; Hunter WN; Gamarro F; Piras S; Loriga M; Allecca S; Corona P; McLuskey K; Tulloch L; Gibellini F; Ferrari S; Costi MP
Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1448-53. PubMed ID: 18245389
[TBL] [Abstract][Full Text] [Related]
10. Characterization of quinonoid-dihydropteridine reductase (QDPR) from the lower eukaryote Leishmania major.
Lye LF; Cunningham ML; Beverley SM
J Biol Chem; 2002 Oct; 277(41):38245-53. PubMed ID: 12151409
[TBL] [Abstract][Full Text] [Related]
11. New approaches to Leishmania chemotherapy: pteridine reductase 1 (PTR1) as a target and modulator of antifolate sensitivity.
Nare B; Luba J; Hardy LW; Beverley S
Parasitology; 1997; 114 Suppl():S101-10. PubMed ID: 9309772
[TBL] [Abstract][Full Text] [Related]
12. The role of reduced pterins in resistance to reactive oxygen and nitrogen intermediates in the protozoan parasite Leishmania.
Moreira W; Leblanc E; Ouellette M
Free Radic Biol Med; 2009 Feb; 46(3):367-75. PubMed ID: 19022374
[TBL] [Abstract][Full Text] [Related]
13. Regulation of differentiation to the infective stage of the protozoan parasite Leishmania major by tetrahydrobiopterin.
Cunningham ML; Titus RG; Turco SJ; Beverley SM
Science; 2001 Apr; 292(5515):285-7. PubMed ID: 11303103
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of the Leishmania tarentolae pterin transporter (BT1) and reductase (PTR1) genes leads to viable parasites with changes in folate metabolism and hypersensitivity to the antifolate methotrexate.
El Fadili A; Kündig C; Roy G; Ouellette M
J Biol Chem; 2004 Apr; 279(18):18575-82. PubMed ID: 14981076
[TBL] [Abstract][Full Text] [Related]
15. Dual and selective inhibitors of pteridine reductase 1 (PTR1) and dihydrofolate reductase-thymidylate synthase (DHFR-TS) from
Teixeira BVF; Teles ALB; Silva SGD; Brito CCB; Freitas HF; Pires ABL; Froes TQ; Castilho MS
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1439-1450. PubMed ID: 31409157
[TBL] [Abstract][Full Text] [Related]
16. Dissecting the metabolic roles of pteridine reductase 1 in Trypanosoma brucei and Leishmania major.
Ong HB; Sienkiewicz N; Wyllie S; Fairlamb AH
J Biol Chem; 2011 Mar; 286(12):10429-38. PubMed ID: 21239486
[TBL] [Abstract][Full Text] [Related]
17. Leishmania major pteridine reductase 1 belongs to the short chain dehydrogenase family: stereochemical and kinetic evidence.
Luba J; Nare B; Liang PH; Anderson KS; Beverley SM; Hardy LW
Biochemistry; 1998 Mar; 37(12):4093-104. PubMed ID: 9521731
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of Trypanosoma cruzi pteridine reductase 2 in complex with a substrate and an inhibitor.
Schormann N; Pal B; Senkovich O; Carson M; Howard A; Smith C; Delucas L; Chattopadhyay D
J Struct Biol; 2005 Oct; 152(1):64-75. PubMed ID: 16168672
[TBL] [Abstract][Full Text] [Related]
19. Pterin and folate reduction by the Leishmania tarentolae H locus short-chain dehydrogenase/reductase PTR1.
Wang J; Leblanc E; Chang CF; Papadopoulou B; Bray T; Whiteley JM; Lin SX; Ouellette M
Arch Biochem Biophys; 1997 Jun; 342(2):197-202. PubMed ID: 9186479
[TBL] [Abstract][Full Text] [Related]
20. A pteridine reductase gene ptr1 contiguous to a P-glycoprotein confers resistance to antifolates in Trypanosoma cruzi.
Robello C; Navarro P; Castanys S; Gamarro F
Mol Biochem Parasitol; 1997 Dec; 90(2):525-35. PubMed ID: 9476799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
